These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 26718446)

  • 1. Expanded carrier screening: A review of early implementation and literature.
    Lazarin GA; Haque IS
    Semin Perinatol; 2016 Feb; 40(1):29-34. PubMed ID: 26718446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current recommendations: Screening for Mendelian disorders.
    Rose NC; Wick M
    Semin Perinatol; 2016 Feb; 40(1):23-8. PubMed ID: 26706396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Carrier Screening in the Twenty-first Century.
    Yao R; Goetzinger KR
    Clin Lab Med; 2016 Jun; 36(2):277-88. PubMed ID: 27235912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on population-based preconception and prenatal cystic fibrosis carrier screening.
    Nolen AA; Rhoades ED
    J Okla State Med Assoc; 2003 Oct; 96(10):482-4. PubMed ID: 14619603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier testing in children and adolescents.
    Vears DF; Metcalfe SA
    Eur J Med Genet; 2015 Dec; 58(12):659-67. PubMed ID: 26563495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Making a (cautious) case for expanding reproductive genetic carrier screens: Australian researchers report success, and caveats, with a simultaneous panel of cystic fibrosis, fragile X syndrome, and spinal muscular atrophy.
    Am J Med Genet A; 2018 Mar; 176(3):510-512. PubMed ID: 29446568
    [No Abstract]   [Full Text] [Related]  

  • 7. Ethnicity-Based Carrier Screening.
    King JR; Klugman S
    Obstet Gynecol Clin North Am; 2018 Mar; 45(1):83-101. PubMed ID: 29428288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic carrier screening for spinal muscular atrophy and spinal muscular atrophy with respiratory distress 1 in an isolated population in Israel.
    Basel-Vanagaite L; Taub E; Drasinover V; Magal N; Brudner A; Zlotogora J; Shohat M
    Genet Test; 2008 Mar; 12(1):53-6. PubMed ID: 18298318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of preconceptional carrier screening for cystic fibrosis and haemoglobinopathies: a sociotechnical analysis.
    Achterbergh R; Lakeman P; Stemerding D; Moors EH; Cornel MC
    Health Policy; 2007 Oct; 83(2-3):277-86. PubMed ID: 17368860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population screening for reproductive risk for single gene disorders in Australia: now and the future.
    Delatycki MB
    Twin Res Hum Genet; 2008 Aug; 11(4):422-30. PubMed ID: 18637742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carrier screening for cystic fibrosis.
    Dungan JS
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):47-59, Table of Contents. PubMed ID: 20494257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?
    Fares F; Badarneh K; Abosaleh M; Harari-Shaham A; Diukman R; David M
    Prenat Diagn; 2008 Mar; 28(3):236-41. PubMed ID: 18264947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current controversies in traditional and expanded carrier screening.
    Lazarin GA; Goldberg JD
    Curr Opin Obstet Gynecol; 2016 Apr; 28(2):136-41. PubMed ID: 26844860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public Perceptions of Recessive Carrier Testing in the Preconception and Prenatal Periods.
    Shiroff JJ; Nemeth LS
    J Obstet Gynecol Neonatal Nurs; 2015; 44(6):717-25. PubMed ID: 26469803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive carrier genetic test using next-generation deoxyribonucleic acid sequencing in infertile couples wishing to conceive through assisted reproductive technology.
    Martin J; Asan ; Yi Y; Alberola T; Rodríguez-Iglesias B; Jiménez-Almazán J; Li Q; Du H; Alama P; Ruiz A; Bosch E; Garrido N; Simon C
    Fertil Steril; 2015 Nov; 104(5):1286-93. PubMed ID: 26354092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for single gene genetic disease.
    Musci TJ
    Gynecol Obstet Invest; 2005; 60(1):19-26. PubMed ID: 15731563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possibilities and barriers in the implementation of a preconceptional screening programme for cystic fibrosis carriers: a focus group study.
    Poppelaars FA; van der Wal G; Braspenning JC; Cornel MC; Henneman L; Langendam MW; ten Kate LP
    Public Health; 2003 Nov; 117(6):396-403. PubMed ID: 14522154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on cystic fibrosis screening.
    Goetzinger KR; Cahill AG
    Clin Lab Med; 2010 Sep; 30(3):533-43. PubMed ID: 20638569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeled Fetal Risk of Genetic Diseases Identified by Expanded Carrier Screening.
    Haque IS; Lazarin GA; Kang HP; Evans EA; Goldberg JD; Wapner RJ
    JAMA; 2016 Aug; 316(7):734-42. PubMed ID: 27533158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.
    Massie J; Forbes R; Dusart D; Bankier A; Delatycki MB
    J Paediatr Child Health; 2007 Nov; 43(11):721-3. PubMed ID: 17924936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.